Therapeutic Nuclear Medicines Market Worth Observing Growth Top Key Player- Bayer AG, Novartis AG, GE Healthcare, Curium Pharmaceuticals, Eckert & Ziegler and International Isotopes Inc.

1
Therapeutic Nuclear Medicines Market Financial
Guide for 2028 by Leading Players- Bayer AG,
Novartis AG, GE Healthcare, Curium
Pharmaceuticals and Others

• Feb 2021

Report Id REP-GB-2930 Published On
14-Jan-2019 Category Healthcare,
Pharmaceuticals Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)

• Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)

• Identifying key opinion leaders
• Questionnaire design
• In-depth interviews
• Coverage across value chain

• Key industry experts
• Channel study
• Developments
• Market dynamics
• Products
• Conclusions

SOLUTION

• Market participants
• Key strengths
• Product portfolio
• Mapping as per value chain
• Key focus segments

Primary Research
Secondary Research
Paid Publications

• Linkedin
• Zoominfo
• Salesforce
• Avention

• Factiva
• GBI
• Genios
• Meltwater

• Company websites
• Company annual reports
• White papers
• Financial reports

includes sources of databases
4
Therapeutic Nuclear Medicines Market Analysis
Increasing acceptance of therapeutic nuclear
medicines (or radiopharmaceuticals) among
industry experts will remain a prominent factor
encouraging their adoption. Though associated
with a negligible risk factor, radiopharmaceutical
s are likely to witness growing recommendation
owing to no proven significant adverse
effects. In the backdrop of the growing
criticality of a more reliable, safer, and lesser
harmful line of treatment for cancers,
therapeutic nuclear medicines are being
increasingly perceived as the potential treatment
for cancer patients. Moreover, consistently
surging instances of bone metastases further
supports adoption growth, in the therapeutic
nuclear medicines market. Just-under 10 Annual
Growth Projected for Radiopharmaceuticals
Adoption A recent market research intelligence by
Future Market Insights focuses on the deep-dive
evaluation of global therapeutic nuclear
medicines landscape, emphasizing the analysis of
the most influential factors responsible for
surging acceptance of radiopharmaceuticals in
treating a range of cancers and a few other
chronic conditions. Request a Sample of this
Report _at_ https//www.futuremarketinsights.com/repo
rts/sample/rep-gb-2930
5
Therapeutic Nuclear Medicines Market Analysis

• The study projects robust progress for the global
  radiopharmaceuticals market in coming years,
  reportedly driven by remarkable adoption in the
  treatment of prostate cancer. In 2019, the global
  demand for therapeutic nuclear medicines is
  expected to grow at a 9.7 annual rate, and
  maximum adoption is estimated by cancer research
  institutes at a global level.
• North America, jointly with Western Europe,
  represents more than 65 share of the total
  market value.
• Outpacing developed regional markets, the
  radiopharmaceuticals market in China and emerging
  economies across Asia Pacific, Latin America, and
  Middle East Africa are slated for higher year
  on year revenue growth of over 12 in 2019 and
  ahead.
• China is reportedly the most lucrative market for
  penetration of therapeutic nuclear medicines,
  which is attributed to an expanding cancer
  patient pool in the country and a consistently
  surging rate of radiopharmaceuticals
  recommendation.
• Top Three Companies Account for More than 87
  Market Value Share
• A highly consolidated marketplace, global
  therapeutic nuclear medicines landscape is
  dominated by Bayer AG that currently accounts for
  just-under 80 revenue share in market.

6
Therapeutic Nuclear Medicines Market Analysis

• The top three players include GE Healthcare and
  Novartis AG other than Bayer, which collectively
  cover over 87 of the total valuation of
  radiopharmaceuticals market. While exceptional
  sales and success rate of Xofigo have been
  prominently retaining Bayers top position in the
  global market, strategic acquisitions are
  identified to be the key strategy behind
  Novartis success at a global level.
• Get Full Report Buy Now _at_ https//www.futuremarket
  insights.com/checkout/2930
• Thorough assessment of the competitive landscape
  of global therapeutic medicines market reveals a
  few prominent developmental strategies adopted by
  a majority of key companies operating in
  radiopharmaceuticals landscape
• Investments in RD of targeted cancer
  therapeutics
• Stronger supply chain and more streamlined
  distribution network
• Improved flagship product sales
• Strategic collaborations with pharma/biopharmaceut
  ical companies
• Contractual relationships with domestic/regional
  stakeholders

7
Therapeutic Nuclear Medicines Market Analysis

• Strategic deals with internationally recognized
  cancer research institutes
• Over 20 Growth Forecast for Erbium-169
• Radium-223 has been the highest recommended type
  of radionucleotide in radiopharmaceuticals
  market. While it currently accounts for a
  whopping 78 share in the global market revenue,
  it is more likely that Erbium-169 that has been
  witnessing higher traction in recent past would
  witness relatively higher revenue growth in
  coming years. The report forecasts over 20 year
  on year revenue growth for Erbium-169 in 2019.
• Request for Report Ask A Question _at_
  https//www.futuremarketinsights.com/ask-question/
  rep-gb-2930
• Exceptional Growth Projections for Thyroid
  Brain Cancer
• While over half the global market value is
  accounted by the adoption of therapeutic nuclear
  medicines for treatment of prostate cancer, bone
  metastases also accounts for sizable revenue
  generation in the market. Brain tumor and thyroid
  cancer are likely to emerge highly lucrative
  targets for manufacturers of therapeutic nuclear
  medicines, according to the report.

8
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)